Fundamental Analysis
89 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +1006.4% | +800.5% | 3 / 3 | +33.1% | +4.70 pp | +2.83 pp | +3.6% | 0.50 | 6.75 | 214 | +33,1% | 6,9 | +1.006,4% | 6.75 | 20.34 | −66,8% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 2.600 (close price on 2026-10-19)EPS (TTM): 385,2
Financial charts
1.Revenue & growth
VND bn194Q2/26
1.Revenue & growth
VND bn194Q2/26
2.Profit & growth
VND bn6,90Q2/26
3.Profit mix (Penman)
VND bn12,5Q2/26
4.Margins & cost structure
%7.8%Q2/26
5.Returns & cash cycle
% · days4.4%Q2/26
6.Earnings quality & cash
VND bn-15,9Q2/26
7.Asset structure
VND bn604Q2/26
8.Funding & debt health
VND bn · times604Q2/26
9.Revenue backlog
VND bn4,16Q2/26
10.Valuation
times · %6,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %217Q2/26
Adjusted EPS growth, latest quarter
11,1× higher
Average adjusted EPS growth, 3 quarters
800%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26